Th2‐high asthma is characterized by eosinophilic airway inflammation, also known as type 2 inflammation, primarily mediated by Th2 and ILC2 cells and involving pathways such as IL‐4/IL‐13, IL‐5, and IL‐25/IL‐33/TSLP. The gene discussed is IL13; the disease is asthma.